Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
ISG15-driven immune modulation and tumor progression in breast cancer metastasis: insights from single-cell and spatial transcriptomics.
PMID 41639695 · PMC12958617 · BMC medicine · 2026 · 8 claims · 8 setups
CSC proportion is elevated in lymph node metastatic tumor tissue (BRCA_LNMT) compared to primary tumor (BRCA_PT)
-
Full-text index only
IFN signaling is associated with radiotherapy response in malignant peripheral nerve sheath tumors.
PMID 41766654 · PMC12948414 · The Journal of clinical investigation · 2026 · 8 claims · 8 setups
MPNST cells are more radioresistant than benign plexiform neurofibroma (pNF) cells in vitro
-
Full-text index only
Histone methyl-transferase G9a inhibition boosts the efficacy of immune checkpoint inhibitors in experimental hepatocellular carcinoma.
PMID 41923620 · PMC13130624 · Cell reports. Medicine · 2026 · 7 claims · 8 setups
G9a expression inversely correlates with gene signatures predictive of favorable ICI response across multiple HCC patient cohorts
-
Full-text index only
AJUBA: The Master Regulator Bridging EMT and Immune Evasion in Colorectal Cancer.
PMID 41814682 · PMC13140425 · Mediators of inflammation · 2026 · 8 claims · 8 setups
AJUBA is markedly upregulated in CRC across multiple transcriptomic cohorts and is enriched in epithelial cells with activated EMT features
-
Full-text index only
Integrating single-cell and bulk transcriptomes to reveal prognostic and immunological features of ecDNA-related genes in osteosarcoma.
PMID 42047819 · PMC13125642 · Cancer immunology, immunotherapy : CII · 2026 · 7 claims · 8 setups
A novel ecDNA-related Gene Prognostic Score Model (EGPSM) was constructed using an integrated framework of 101 machine learning algorithm combinations and validated in training, testing, and external cohorts.
-
Full-text index only
Multi-omics analyses related to unfolded protein response in prostate cancer implicate pro-tumor role of IFRD1.
PMID 41694360 · PMC12894258 · Frontiers in immunology · 2026 · 8 claims · 8 setups
Luminal prostate epithelial cells, especially the LE-KLK3 subpopulation, show elevated UPR activity compared to other cell types
-
Full-text index only
Development and validation of a gemcitabine sensitivity-related long noncoding RNA signature for predicting the prognosis and subtypes of bladder cancer.
PMID 41809777 · PMC12968932 · Translational andrology and urology · 2026 · 8 claims · 8 setups
A 37-GSRlncRNA prognostic signature stratifies BLCA patients into low- and high-risk groups with significant differences in survival, pathway enrichment, immune infiltration, and mutational profiles
-
Full-text index only
FOXA1 loss drives basal/squamous de-differentiation of prostate cancer and induces an immunosuppressive tumor microenvironment.
PMID 41904157 · PMC13195071 · Nature communications · 2026 · 7 claims · 8 setups
Prostate-specific Foxa1 deletion in Pten-null mice drives tumor progression by reprogramming luminal PCa cells toward a basal/squamous-like de-differentiated state
-
Full-text index only
Multi-Omics reveals SPP1 + malignant and CXCR4(+) TAM crosstalk predicts immunotherapy response in lung adenocarcinoma.
PMID 42045760 · PMC13187092 · Discover oncology · 2026 · 8 claims · 8 setups
SPP1+ malignant and CXCR4+ TAM crosstalk drives CD8 T cell exhaustion and induces poor immunotherapy response
-
Has reproduction · 61
Multi-omics analyses identify mannose phosphate isomerase-centered hypoxia-induced angiogenesis signature in colorectal cancer.
PMID 41204349 · PMC12595641 · Journal of translational medicine · 2025 · 8 claims · 8 setups
Twelve HIA-related genes were identified that are transcriptionally activated by HIF1A/HIF2A and functionally implicated in angiogenesis in CRC
-
Full-text index only
Proteomic and genetic approaches identify Syk as an AML target.
PMID 19800574 · PMC2803063 · Cancer cell · 2009 · 8 claims · 8 setups
EGFR inhibitors (e.g., gefitinib) induce AML differentiation through a non-EGFR, off-target mechanism